Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. - Wikidata - wikimedia - TriplyDB

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

http://www.wikidata.org/entity/Q35678051

about

Peptide-Based Treatment: A Promising Cancer Therapy Urinary kallikrein 10 predicts the incurability of gastric cancer Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.Anticancer Effects of Baicalein in Pancreatic Neuroendocrine Tumors In Vitro and In Vivo.TIMPs: versatile extracellular regulators in cancer.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.

P2860

Q26777032-FC9C1FC8-B07F-4BA3-8C7A-3B9566E29E15 Q33710081-593C30A8-3970-4EB1-9F9F-D20BF63605B7 Q35145167-7F2E9C70-BA95-403F-B172-104A7675AB60 Q35828503-620B1E9F-C9CA-4DDF-8B82-2573FE8EEBFE Q36156149-EC542133-7500-429C-9105-D9D854ADA346 Q36420282-F1614A04-FBA1-4630-BEBA-05D06E921047 Q38695511-A0F7BAC7-F026-4D26-AF49-C0278A243413 Q38785433-ECD7125B-FE49-4294-A255-BBD1299669A2 Q41624551-AB7E0088-A833-40E7-9534-B6ABB1B41244 Q55424250-60C065D9-2C8E-42E7-87AE-B6B44D41E1D3

P2860

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

http://www.wikidata.org/entity/Q35678051

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@ast

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@en

type

label

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@ast

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@en

prefLabel

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@ast

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@en

P1433

Q35678051-DEA19C23-D783-4429-BE9D-87A1F5F563DA

P1476

Q35678051-DFB988C5-3E68-4A87-9E3F-379D288238DF

P2093

Q35678051-0EAD807E-CFB7-4800-A834-B323FC58536F

Q35678051-2E24CC60-3F18-4EEA-A26F-E6172C24A3DA

Q35678051-3C55C4B3-90D4-46DC-BA88-CE64AB0F85E5

Q35678051-64EE4368-5263-46C9-86FE-76228B450BD4

Q35678051-773CB23E-58DB-4A86-A398-E6DC870BBB21

Q35678051-7BC1F18D-79AE-459E-A731-CCCDCAA83ACB

Q35678051-B71F67AB-19B5-4A78-95C9-DFB4FF2165CC

P2860

Q35678051-001370D8-2AAA-4BCA-9FF4-CF05AB64368C

Q35678051-09590526-E8BE-40D8-9BF8-16C572C7325C

Q35678051-0BE8DBD1-6003-40E0-841E-0F76B3EE1A46

Q35678051-1BFF7938-92E9-46E8-B500-0B6816E2375B

Q35678051-22494A80-49DC-45BD-9700-E58CC9657D6A

Q35678051-281A038B-2EE0-421E-AAFC-8CC920D3A9D2

Q35678051-2BD3FD60-FC54-4145-83B4-1B135F0207C8

Q35678051-30A613A0-9577-460C-911D-423F8B59D382

Q35678051-3B3BEE7E-4780-4F80-8359-3FC5E9ED2E67

Q35678051-42C3833A-9F52-4944-B777-4AF26AE32B55

P2888

Q35678051-1E10F0C7-AED0-48F2-B334-389EE0F220F5

P304

Q35678051-4F5C0978-26F4-4A2F-AEDE-409DC79F1795

P31

Q35678051-67D10FFC-598D-4CC1-8771-7E3BDF38750A

P356

Q35678051-DCFE3F1F-C298-423E-94B9-645BF6A36FB2

P407

Q35678051-945C0D0E-E64B-43E2-B9E1-3F51F01FD009

P433

Q35678051-9F89DBD8-E4F7-49FB-9716-A93DDA27498A

P478

Q35678051-82436147-EF71-4552-BD4D-5287F874C60A

P577

Q35678051-1CFFD0C1-55AB-4434-A3A4-B709B6C2C08C

P5875

Q35678051-DF61FF9D-5793-4952-8491-A8715F5BA821

P6179

Q35678051-1D951892-0F0E-4B52-A5F0-F0338EC76F51

P698

Q35678051-6F3FBE79-0C73-4302-8139-937A8390CF5F

P932

Q35678051-EB82A4CB-4C0D-4BD1-9B28-9D49BD2C9CB6

P356

P1433

British Journal of Cancer

P1476

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

@en

P2093

C Frauenhoffer

http://www.w3.org/2001/XMLSchema#string

D Zurakowski

http://www.w3.org/2001/XMLSchema#string

J Wischhusen

http://www.w3.org/2001/XMLSchema#string

M A Moses

http://www.w3.org/2001/XMLSchema#string

M Kulke

http://www.w3.org/2001/XMLSchema#string

R Roy

http://www.w3.org/2001/XMLSchema#string

S Hooshmand

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Early diagnosis of pancreatic cancer: challenges and new developments

Gastroenteropancreatic neuroendocrine tumours

Pancreatic cancer

Pancreatic cancer.

Serum biomarker panels for the detection of pancreatic cancer

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

Expression profiling of microdissected pancreatic adenocarcinomas.

ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.

P2888

P304

1772-1779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.462

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264866650

http://www.w3.org/2001/XMLSchema#string

P6179

1010685537

http://www.w3.org/2001/XMLSchema#string

P698

25137018

http://www.w3.org/2001/XMLSchema#string

P932

4453724

http://www.w3.org/2001/XMLSchema#string